Ask the Expert connects type 1 diabetes focused scientists in a “digital cafe” Register here for upcoming conversations.

Upcoming ATEs

Recent Releases

Ask the Expert: Peter Linsley, PhD, Benaroya Research Institute

The Sugar Science October 21, 2024 2:49 pm

Coming Soon

New Talent in T1D Research

Past Events

Arthur D. Riggs, Ph.D., the world-renowned diabetes expert who developed the technology that led to the first human synthetic insulin for the treatment of diabetes, died March 23 after battling cancer. A biotechnology pioneer and a longtime leader at City of Hope, Riggs’ major scientific discoveries were achieved over more than a half-century of research, paving the way for development of the monoclonal antibody therapies that are the foundation of modern treatments for cancer, autoimmune diseases, blindness and a host of other diseases.

His breakthrough work in diabetes enabled mass production of insulin for people living with the disease. Today, synthetic insulin is used by hundreds of millions of people.

He was 82.

More details about his incredible scientific contributions and life can be found below and here:
https://www.cityofhope.org/breakthroughs/art-riggs-tribute 

Speakers: 
Debbie Thurmond, Ph.D.,  director, Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope
Fouad Kandeel, M.D., Ph.D., chair of Translational Research and Cellular Therapeutics, AR-DMRI, City of Hope
Anna Wu, Ph.D., chair, Department of Immunology & Theranostics, City of Hope
Stephen J. Forman, M.D., director, Hematologic Malignancies Research Institute, City of Hope
Rama Natarajan, Ph.D., chair, Department of Diabetes Complications & Metabolism, City of Hope
Jack Shively, Ph.D., professor, Department of Immunology & Theranostics, City of Hope
David Horne, Ph.D., vice provost and deputy director, Beckman Research Institute, City of Hope

Arthur D. Riggs, Ph.D., the world-renowned diabetes expert who developed the technology that led to the first human synthetic insulin for the treatment of diabetes, died March 23 after battling cancer. A biotechnology pioneer and a longtime leader at City of Hope, Riggs’ major scientific discoveries were achieved over more than a half-century of research, paving the way for development of the monoclonal antibody therapies that are the foundation of modern treatments for cancer, autoimmune diseases, blindness and a host of other diseases.

His breakthrough work in diabetes enabled mass production of insulin for people living with the disease. Today, synthetic insulin is used by hundreds of millions of people.

He was 82.

More details about his incredible scientific contributions and life can be found below and here:
https://www.cityofhope.org/breakthroughs/art-riggs-tribute

Speakers:
Debbie Thurmond, Ph.D., director, Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope
Fouad Kandeel, M.D., Ph.D., chair of Translational Research and Cellular Therapeutics, AR-DMRI, City of Hope
Anna Wu, Ph.D., chair, Department of Immunology & Theranostics, City of Hope
Stephen J. Forman, M.D., director, Hematologic Malignancies Research Institute, City of Hope
Rama Natarajan, Ph.D., chair, Department of Diabetes Complications & Metabolism, City of Hope
Jack Shively, Ph.D., professor, Department of Immunology & Theranostics, City of Hope
David Horne, Ph.D., vice provost and deputy director, Beckman Research Institute, City of Hope

YouTube Video UExwbVpwcHZGSzZiWmtHMmRpMXJubmtZY2RCNHl2QTl4dC5EQTkxMkVFODRENEJBMERF

Riggs Remembered: In Memoriam of Diabetes Research Pioneer Dr. Arthur D. Riggs

The Sugar Science June 8, 2022 9:54 am